However, this same activation of TLR2 can have adverse consequences, because although the initial stimulation of the immune response can increase antitumor immunity, it can also contribute to the formation of an immunosuppressive microenvironment, since TLR2 influences regulatory immune cells that can inhibit the immune response against the tumor. The gene discussed is TLR2; the disease is neoplasm.